Evidence map›Paper›PMID 41476750›Full record

ArticleMaterials today. Bio2026

Supramolecularly gated enzymes: On-demand activity switching via host-guest competition for precision tumor therapy.

Huijuan Yang, Xiangrui Shi, Ziyi Li, Lan Yang, Xinlei Gao, Hui Chen, Qinghua Zhang, Fengting Lv, Xuli Feng

Abstract read
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huijuan YangChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.
Xiangrui ShiChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.
Ziyi LiChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.
Lan YangChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.
Xinlei GaoChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.
Hui ChenChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.
Qinghua ZhangDepartment of Obstetrics and Gynecology, Daping Hospital, Army Medical University, Chongqing, 400042, PR China.
Fengting LvBeijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, PR China.
Xuli FengChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dynamic control over enzyme function has been of great interest in the field of enzyme engineering and disease treatment, however, achieving on-demand regulation of native enzymes in living systems remains challenging due to the complexity of cellular environments and the lack of selective interactions. Here, we introduce a novel enzyme activity regulation system based on supramolecular host-guest recognition that enables reversible and on-demand regulation of native enzyme activity in living cells without covalent modification. This system utilizes the high-affinity interaction between cucurbit[7]uril (CB[7]) and amantadine (Ad) to precisely control enzyme function. CB[7] binds to key residues on the enzyme surface, blocking the active site and switching off enzyme activity. Upon intracellular administration of Ad, CB[7] is competitively removed, restoring enzyme activity and allowing for dynamic regulation of cellular functions. This strategy was successfully validated with model enzymes, including catalase (CAT) and β-galactosidase (β-Gal), demonstrating its broad applicability. Furthermore, we extended this approach to enzyme/prodrug therapy, achieving localized prodrug activation and targeted cell death while minimizing off-target effects and systemic toxicity. Thus, this non-covalent, reversible regulation of enzyme activity represents a significant advancement over traditional methods, offering a versatile and biocompatible tool for studying protein function and developing targeted therapeutic strategies.

Indexed as

Cellular enzyme regulationNon-covalent modificationProdrug activationReversible controlSupramolecular recognition

Identifiers

PMID41476750
PMCPMC12753241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.